These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity]. Rosolová H, Cech J, Sefrna F. Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546 [Abstract] [Full Text] [Related]
5. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Tytus RH, Burgess ED, Assouline L, Vanjaka A. Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822 [Abstract] [Full Text] [Related]
6. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril]. Motero Carrasco J. Arch Inst Cardiol Mex; 1997 Feb; 67(1):29-37. PubMed ID: 9221708 [Abstract] [Full Text] [Related]
7. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors. McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K, Sibutramine in Hypertensives Clinical Study Group. J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224 [Abstract] [Full Text] [Related]
9. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison. Lee HY, Kang HJ, Koo BK, Oh BH, Heung-Sun K, Kim KS, Seo HS, Ro YM, Kang JH, Woong CJ, Joo SJ, Kim MH, Joon-Han S, Yoon J, Park SH, Jin-Ok J, Ju AK, Chong-Yun R, Yeon KJ, Park KM, Lim DK, Park SY, Amostar Study Investigators. Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979 [Abstract] [Full Text] [Related]
10. [Therapy of hypertension in the elderly: Fosinopril in Old Patients Study (FOPS)]. Koch J, Greminger P, Simeon-Dubach D. Praxis (Bern 1994); 1997 Nov 05; 86(45):1779-84. PubMed ID: 9446181 [Abstract] [Full Text] [Related]
11. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group. Misra KP, Joglekar SJ, Mukherjee S, Nanivadekar AS. J Assoc Physicians India; 1998 Nov 05; Suppl 1():30-40. PubMed ID: 11233385 [Abstract] [Full Text] [Related]
14. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial. Pathak L, Hiremath, Kerkar PG, Manade VG. J Assoc Physicians India; 2004 Mar 05; 52():197-202. PubMed ID: 15636308 [Abstract] [Full Text] [Related]
15. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D. Clin Ther; 2005 May 05; 27(5):578-87. PubMed ID: 15978306 [Abstract] [Full Text] [Related]
16. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison. Lijnen P, Fagard R, Staessen J, Amery A. Methods Find Exp Clin Pharmacol; 1990 Oct 05; 12(8):563-73. PubMed ID: 2151197 [Abstract] [Full Text] [Related]